001     183570
005     20240619091937.0
024 7 _ |2 doi
|a 10.1002/ejlt.201400066
024 7 _ |2 ISSN
|a 0015-038X
024 7 _ |2 ISSN
|a 0367-2107
024 7 _ |2 ISSN
|a 0367-3278
024 7 _ |2 ISSN
|a 0931-5985
024 7 _ |2 ISSN
|a 1438-7697
024 7 _ |2 ISSN
|a 1438-9312
024 7 _ |2 ISSN
|a 1521-4133
024 7 _ |2 WOS
|a WOS:000343000600008
037 _ _ |a FZJ-2014-06864
082 _ _ |a 660
100 1 _ |0 P:(DE-HGF)0
|a Khoshakhlagh, Pooneh
|b 0
|e Corresponding Author
245 _ _ |a Nanoparticle structure development in the gastro-intestinal model fluid FaSSIF mod6.5 from several phospholipids at various water content relevant for oral drug administration
260 _ _ |a Weinheim
|b Wiley-VCH
|c 2014
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1422628704_18301
|2 PUB:(DE-HGF)
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|0 0
|2 EndNote
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a article
|2 DRIVER
520 _ _ |a The characteristics of intestinal model fluids were investigated at conditions, which simulate the passage from the middle to the end of the duodenum. The formation and decay of liposomes and micelles in model bile fluids were studied, because of their role as an intermediate host for the resolution and uptake of hydrophobic drugs (BCS classes II, IV). The conditions, which may influence the formation of these nanoparticulate intermediates were studied, i.e., the lipid composition of the bile, the preparation method, the time of the passage through the modelled duodenum segment and the concentration, which results from the variable dilution of the bile by mixing with the transfer medium representing the fluid arriving from the stomach. The variation of the lecithin entity revealed an equivalence of Egg–lecithin of a high purity (99%) with its main component 1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine POPC, while 1,2-di-oleoyl-sn-glycero-3-phosphocholine DOPC resulted in a slight delay of the micelle-liposome conversion. The FeSSIF preparation method was best with the sequential-film method, while the bile-film method yielded comparable results; the shake method showed a slightly different kinetics of the nanoparticle conversion. The time and concentration dependence of the formation and decay of lipidic nanoparticles indicates that these strongly depend on the passage time (speed) and bile dilution rate. The corresponding physiological conditions at healthy persons may vary in vivo individually and due to diseases. The studied conditions cover typical physiological conditions, which should be taken into consideration in the exploration of in vitro tests of formulations of hydrophobic drugs.Formation and decay of liposomes and micelles from bile in the duodenum was studied, due to their role as an intermediate for resolution and uptake of hydrophobic drugs (BCS II, IV). The physiological conditions studied may vary individually and due to diseases.
536 _ _ |0 G:(DE-HGF)POF2-54G24
|a 54G - JCNS (POF2-54G24)
|c POF2-54G24
|f POF II
|x 0
588 _ _ |a Dataset connected to CrossRef, juser.fz-juelich.de
650 2 7 |a Medicine
|0 V:(DE-MLZ)SciArea-190
|2 V:(DE-HGF)
|x 1
650 2 7 |a Soft Condensed Matter
|0 V:(DE-MLZ)SciArea-210
|2 V:(DE-HGF)
|x 0
650 1 7 |a Health and Life
|0 V:(DE-MLZ)GC-130-2016
|2 V:(DE-HGF)
|x 2
650 1 7 |a Health and Life
|0 V:(DE-MLZ)GC-130-1
|2 V:(DE-HGF)
|x 1
650 1 7 |a Life Science and Health
|0 V:(DE-MLZ)GC-130
|2 V:(DE-HGF)
|x 0
693 _ _ |0 EXP:(DE-MLZ)KWS2-20140101
|1 EXP:(DE-MLZ)FRMII-20140101
|5 EXP:(DE-MLZ)KWS2-20140101
|6 EXP:(DE-MLZ)NL3ao-20140101
|a Forschungs-Neutronenquelle Heinz Maier-Leibnitz
|e KWS-2: Small angle scattering diffractometer
|f NL3ao
|x 0
700 1 _ |0 P:(DE-HGF)0
|a Johnson, Raphael
|b 1
700 1 _ |0 P:(DE-HGF)0
|a Nawroth, Thomas
|b 2
700 1 _ |0 P:(DE-HGF)0
|a Langguth, Peter
|b 3
700 1 _ |0 P:(DE-HGF)0
|a Schmueser, Lars
|b 4
700 1 _ |0 P:(DE-HGF)0
|a Hellmann, Nadja
|b 5
700 1 _ |0 P:(DE-HGF)0
|a Decker, Heinz
|b 6
700 1 _ |0 P:(DE-Juel1)145431
|a Szekely, Noemi
|b 7
773 _ _ |0 PERI:(DE-600)2012720-0
|a 10.1002/ejlt.201400066
|g Vol. 116, no. 9, p. 1155 - 1166
|n 9
|p 1155 - 1166
|t European journal of lipid science and technology
|v 116
|x 1438-7697
|y 2014
909 C O |o oai:juser.fz-juelich.de:183570
|p VDB:MLZ
|p VDB
910 1 _ |0 I:(DE-588b)5008462-8
|6 P:(DE-Juel1)145431
|a Forschungszentrum Jülich GmbH
|b 7
|k FZJ
913 2 _ |0 G:(DE-HGF)POF3-600
|1 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF
|9 G:(DE-HGF)POF3-6G15
|a DE-HGF
|b Programmorientierte Förderung
|l POF III
|v Forschungsbereich Materie
|x 0
913 2 _ |0 G:(DE-HGF)POF3-623
|1 G:(DE-HGF)POF3-620
|2 G:(DE-HGF)POF3-600
|9 G:(DE-HGF)POF3-6G4
|a DE-HGF
|b Forschungsbereich Materie
|l Von Materie zu Materialien und Leben
|v Facility topic: Neutrons for Research on Condensed Matter
|x 1
913 1 _ |0 G:(DE-HGF)POF2-54G24
|1 G:(DE-HGF)POF2-540
|2 G:(DE-HGF)POF2-500
|a DE-HGF
|b Struktur der Materie
|v JCNS
|x 0
|4 G:(DE-HGF)POF
|3 G:(DE-HGF)POF2
|l Forschung mit Photonen, Neutronen, Ionen
914 1 _ |y 2014
915 _ _ |0 StatID:(DE-HGF)0100
|2 StatID
|a JCR
915 _ _ |0 StatID:(DE-HGF)0110
|2 StatID
|a WoS
|b Science Citation Index
915 _ _ |0 StatID:(DE-HGF)0111
|2 StatID
|a WoS
|b Science Citation Index Expanded
915 _ _ |0 StatID:(DE-HGF)0150
|2 StatID
|a DBCoverage
|b Web of Science Core Collection
915 _ _ |0 StatID:(DE-HGF)0199
|2 StatID
|a DBCoverage
|b Thomson Reuters Master Journal List
915 _ _ |0 StatID:(DE-HGF)0200
|2 StatID
|a DBCoverage
|b SCOPUS
915 _ _ |0 StatID:(DE-HGF)0300
|2 StatID
|a DBCoverage
|b Medline
915 _ _ |0 StatID:(DE-HGF)0310
|2 StatID
|a DBCoverage
|b NCBI Molecular Biology Database
915 _ _ |0 StatID:(DE-HGF)1050
|2 StatID
|a DBCoverage
|b BIOSIS Previews
915 _ _ |0 StatID:(DE-HGF)1060
|2 StatID
|a DBCoverage
|b Current Contents - Agriculture, Biology and Environmental Sciences
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)JCNS-FRM-II-20110218
|k JCNS (München) ; Jülich Centre for Neutron Science JCNS (München) ; JCNS-FRM-II
|l JCNS-FRM-II
|x 0
920 1 _ |0 I:(DE-Juel1)JCNS-1-20110106
|k Neutronenstreuung ; JCNS-1
|l Neutronenstreuung
|x 1
920 1 _ |0 I:(DE-Juel1)ICS-1-20110106
|k ICS-1
|l Neutronenstreuung
|x 2
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-Juel1)JCNS-FRM-II-20110218
980 _ _ |a I:(DE-Juel1)JCNS-1-20110106
980 _ _ |a I:(DE-Juel1)ICS-1-20110106
980 _ _ |a UNRESTRICTED
981 _ _ |a I:(DE-Juel1)IBI-8-20200312
981 _ _ |a I:(DE-Juel1)JCNS-1-20110106
981 _ _ |a I:(DE-Juel1)ICS-1-20110106


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21